Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany

【24h】

Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany

机译：激素受体阳性/海洋阳性和HER2阳性肿瘤患者的晚期乳腺癌的治疗在现实生活中变化：德国晚期乳腺癌患者前瞻性国家研究平台蛋白石的首先结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：激素受体阳性/海洋阳性和HER2阳性肿瘤患者的晚期乳腺癌的治疗在现实生活中变化：德国晚期乳腺癌患者前瞻性国家研究平台蛋白石的首先结果
2. ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany [J] . Maass Nicolai, Ostermann Helmut, Possinger Kurt, Breast care . 2019,第6期

机译：德国先进激素受体阳性乳腺癌晚期患者在绝经后患者中探索治疗模式，探索治疗模式。
3. A real-life study on everolimus plus exemestane therapy in a cohort of HR-positive, HER2-negative postmenopausal advanced breast cancer patients; A study of the SOutheast Netherlands Advanced BREast cancer (SONABRE) Registry [J] . Knapen L. M., Geurts S. M. E., De Boer M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：对艾弗里莫姆斯和高血球治疗的真实研究，Her2阴性绝经后期晚期乳腺癌患者的群体; 荷兰东南部乳腺癌（Sonabre）注册表的研究
4. Characterizing tumor changes during neoadjuvant treatment of locally advanced breast cancer patients (LABC) using dynamicenhanced magnetic resonance imaging (DE-MRI) [C] . Oana I. Craciunescu, Ellen L. Jones, Kimberly L. Blackwell, Society of Photo-Optical Instrumentation Engineers (SPIE);SPIE Proceedings . 2005

机译：使用动态增强磁共振成像（DE-MRI）表征局部晚期乳腺癌患者（LABC）新辅助治疗期间的肿瘤变化
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. ACT-FASTER a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany [O] . Nicolai Maass, Helmut Ostermann, Kurt Possinger, 2019

机译：德国先进激素受体阳性乳腺癌晚期患者在绝经后患者中探索治疗模式探索治疗模式。
7. Patients’ preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments [O] . Surachat Ngorsuraches, Klangjai Thongkeaw 2015

机译：标准治疗失败后，患者对绝经后激素受体阳性，HER2阴性的晚期乳腺癌治疗的偏爱和支付意愿

Therapy of advanced breast cancer for patients with hormone receptor-positive/HER2-negative and HER2-positive tumors is changing in real life: First results from the prospective, national research platform OPAL for patients with advanced breast cancer in Germany

著录项

相似文献

相关主题

期刊订阅